-

AI in Biotechnology Research Report 2025-2030: Growing Need for More Effective Drug Discovery and Development Process and Shift to Personalized Medicine Bolster Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The global market for AI in biotechnology was valued at $3.8 billion in 2024. The market is estimated to grow from $4.6 billion in 2025 to $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 20% from 2025 to 2030.

The report analyzes the trends in the global market for AI in biotechnology. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030.

Artificial intelligence (AI) is transforming the biotech industry by enabling faster, more precise and highly scalable operations in genetic engineering, personalized medicine, agricultural biotech and drug discovery. Biotech companies are using machine learning (ML) algorithms to evaluate complex biological data, predict protein structures, discover new drug candidates and improve diagnostic accuracy, including predictive analytics for early disease identification. AI also helps in optimizing manufacturing processes and supply chains, enabling it to have an impact across the entire biotech value chain.

The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. It offers company profiles that covers such details as financials, product portfolio and recent developments. It analyzes companies' environmental, social and corporate governance (ESG) initiatives.

Report Includes

  • 50 data tables and 57 additional tables
  • An analysis of the current and future global markets for artificial intelligence (AI) in biotechnology
  • Analyses of the global market trends, with historic revenue data (sales figures) from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
  • Estimates of the size of the market and revenue prospects, along with a corresponding market share analysis based on product type, application, deployment type, end user, and region
  • Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects and the impact of macroeconomic variables
  • Discussion of the underlying opportunities and potential, with the development of novel products, drug discovery, clinical trials and other related applications
  • Insights derived from Porter's Five Forces model and global supply chain analyses
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
  • Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of the leading companies, including NVIDIA Corp., Tempus AI Inc., Recursion Pharmaceuticals, Schrodinger Inc., and Sophia Genetics

Companies Featured

  • Abcellera Biologics Inc.
  • Absci Corp.
  • Atomwise Inc.
  • Benevolentai
  • Dnanexus Inc.
  • Eurofins Scientific
  • Illumina Inc.
  • Insilico Medicine
  • Nvidia Corp.
  • Qiagen
  • Recursion
  • Schrodinger Inc.
  • Sophia Genetics
  • Tempus Ai Inc.
  • Xtalpi Inc.

Key Attributes:

Report Attribute Details
No. of Pages 142
Forecast Period 2025 - 2030
Estimated Market Value (USD) in 2025 $4.6 Billion
Forecasted Market Value (USD) by 2030 $11.4 Billion
Compound Annual Growth Rate 20.0%
Regions Covered Global

Key Topics Covered:

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary
  • Overview
  • Current Market Scenario
  • Segmental Analysis
  • Regional Market Insights
  • Emerging Technologies
  • Conclusion

Chapter 2 Market Overview

  • Overview
  • Potential Applications of AI in Biotechnology
  • Use Cases
  • Use Case 1: Drug Discovery
  • Use Case 2: Personalized Medicine
  • AI's Impact on the Biotech Value Chain
  • Macroeconomic Factors Analysis
  • Demographic Factors
  • Geopolitical Factors
  • Impact of U.S. Tariffs
  • Porter's Five Forces Analysis

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Need for More Effective Drug Discovery and Development Process
  • Shift to Personalized Medicine
  • Growing Demand for Effective and Early Diagnosis
  • Rising Investments in AI in Biopharmaceuticals
  • Aging Population and the Growing Prevalence of Chronic Diseases
  • Market Restraints
  • Data Quality and Bias
  • Integration Hurdles
  • Ethical Concerns
  • Market Opportunities
  • AI in Synthetic Biology
  • Convergence of AI and Quantum Computing

Chapter 4 Regulatory Landscape

  • Regulatory Scenario
  • United States
  • Europe
  • Asia-Pacific

Chapter 5 Emerging Technologies and Developments

  • Emerging Trends/Technologies
  • Key Takeaways
  • Agentic AI
  • Generative AI
  • Federated Learning
  • Advanced Neural Networks

Chapter 6 Market Segmentation Analysis

  • Overview
  • Segmentation Breakdown
  • Market Analysis by Product Type
  • Key Takeaways
  • Software
  • Services
  • Market Analysis by Deployment Type
  • Key Takeaways
  • Cloud-based
  • On-premises
  • Market Analysis by Application
  • Key Takeaways
  • Drug Discovery
  • Clinical Trials and Optimization
  • Diagnostics
  • Other Applications
  • Market Analysis by End User
  • Key Takeaways
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Manufacturing and Development Organizations
  • Other End Users
  • Geographic Breakdown
  • Market Analysis by Region
  • Key Takeaways
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 7 Competitive Intelligence

  • Key Takeaways
  • Competitive Analysis
  • Strategic Initiatives
  • Mergers and Acquisitions
  • Agreements, Collaborations and Partnerships
  • Investment Landscape

Chapter 8 Sustainability in AI in Biotechnology Market: An ESG Perspective

  • Introduction to ESG
  • Sustainability Trends and Company Initiatives
  • ESG Risk Ratings
  • Concluding Remarks

For more information about this report visit https://www.researchandmarkets.com/r/l768ch

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

2-Day Advanced Veterinary Pharmacovigilance Online Training Course (May 21-22, 2026) with 12 CPD Hours - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Advanced Veterinary Pharmacovigilance Training Course (May 21st - May 22nd, 2026)" has been added to ResearchAndMarkets.com's offering. The purpose of this seminar is to provide a comprehensive, yet practical, assessment of the main requirements of Volume IXB, the new key document on pharmacovigilance guidelines used by the veterinary regulatory authorities to ensure a compliant reporting company. The programme will also consider the potential impact of Brexit on p...

3-Day Online Course: Clinical Research Project Management (April 29th to May 1st, 2026) - Boost Your Clinical Project Success with Agile Methodologies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Research Project Management Training Course (April 29, 2026 and May 1, 2026)" has been added to ResearchAndMarkets.com's offering. Setting up and running clinical research projects is a complex process that needs effective project management. The course includes an emphasis on the need to anticipate, understand, and implement detailed project management activities in a proactive manner. It is essential to manage clinical research projects within the set ti...

Drafting International Commercial Agreements in English: Online Training Course (May 11th-12th, 2026) with 12 CPD Hours - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Drafting International Commercial Agreements in English Training Course (May 11th - May 12th, 2026)" has been added to ResearchAndMarkets.com's offering. Most international agreements are drafted in the English language, irrespective of the nationality of the contracting parties. Language errors in the text and unclear and unconcise phrasing cause confusion and can ultimately lead to a dispute if they go unnoticed at the contract drafting stage. Under the careful g...
Back to Newsroom